» Articles » PMID: 39796698

A Systematic Review of the Applications of Deep Learning for the Interpretation of Positron Emission Tomography Images of Patients with Lymphoma

Overview
Journal Cancers (Basel)
Publisher MDPI
Date 2025 Jan 11
PMID 39796698
Authors
Affiliations
Soon will be listed here.
Abstract

: Positron emission tomography (PET) is a valuable tool for the assessment of lymphoma, while artificial intelligence (AI) holds promise as a reliable resource for the analysis of medical images. In this context, we systematically reviewed the applications of deep learning (DL) for the interpretation of lymphoma PET images. : We searched PubMed until 11 September 2024 for studies developing DL models for the evaluation of PET images of patients with lymphoma. The risk of bias and applicability concerns were assessed using the prediction model risk of bias assessment tool (PROBAST). The articles included were categorized and presented based on the task performed by the proposed models. Our study was registered with the international prospective register of systematic reviews, PROSPERO, as CRD42024600026. : From 71 papers initially retrieved, 21 studies with a total of 9402 participants were ultimately included in our review. The proposed models achieved a promising performance in diverse medical tasks, namely, the detection and histological classification of lesions, the differential diagnosis of lymphoma from other conditions, the quantification of metabolic tumor volume, and the prediction of treatment response and survival with areas under the curve, F1-scores, and values of up to 0.963, 87.49%, and 0.94, respectively. : The primary limitations of several studies were the small number of participants and the absence of external validation. In conclusion, the interpretation of lymphoma PET images can reliably be aided by DL models, which are not designed to replace physicians but to assist them in managing large volumes of scans through rapid and accurate calculations, alleviate their workload, and provide them with decision support tools for precise care and improved outcomes.

References
1.
Cousin F, Louis T, Dheur S, Aboubakar F, Ghaye B, Occhipinti M . Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers (Basel). 2023; 15(7). PMC: 10093736. DOI: 10.3390/cancers15071968. View

2.
Berger A . How does it work? Positron emission tomography. BMJ. 2003; 326(7404):1449. PMC: 1126321. DOI: 10.1136/bmj.326.7404.1449. View

3.
Albano D, Re A, Tucci A, Giubbini R, Bertagna F . Prognostic role of ΔMTV and ΔTLG in Burkitt lymphoma. Ann Nucl Med. 2019; 33(4):280-287. DOI: 10.1007/s12149-019-01338-9. View

4.
Pettit R, Fullem R, Cheng C, Amos C . Artificial intelligence, machine learning, and deep learning for clinical outcome prediction. Emerg Top Life Sci. 2021; . PMC: 8786279. DOI: 10.1042/ETLS20210246. View

5.
Markus A, Kors J, Rijnbeek P . The role of explainability in creating trustworthy artificial intelligence for health care: A comprehensive survey of the terminology, design choices, and evaluation strategies. J Biomed Inform. 2020; 113:103655. DOI: 10.1016/j.jbi.2020.103655. View